Paper42192571
Biophysical assessment of the molecular mechanisms of Tau aggregation and its role in Alzheimer's disease.
Skrehot JT and 1 other. Protein Sci, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Biophysical assessment of the molecular mechanisms of Tau aggregation and its role in Alzheimer's disease. Papers, record 42192571. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42192571
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biophysical assessment of the molecular mechanisms of Tau aggregation and its role in Alzheimer's disease.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| tau Proteins | Major topic |
| Alzheimer Disease | Major topic |
| Protein Aggregation, Pathological | Major topic |
| Humans | |
| Animals | |
| Protein Processing, Post-Translational | |
| Neurofibrillary Tangles | |
| Protein Aggregates |
Source PubMed
References112
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29740275 | Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain. | Front Neurosci | 2018 | https://conductscience.org/library/papers/29740275 | PubMed |
| 2 | 33488497 | Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation. | Front Neurol | 2020 | https://conductscience.org/library/papers/33488497 | PubMed |
| 3 | 15249677 | O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15249677 | PubMed |
| 4 | 9735171 | Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. | Arch Biochem Biophys | 1998 | https://conductscience.org/library/papers/9735171 | PubMed |
| 5 | 18784819 | Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views. | Int J Clin Exp Pathol | 2008 | https://conductscience.org/library/papers/18784819 | PubMed |
| 6 | 38274251 | Mutations in Tau Protein Promote Aggregation by Favoring Extended Conformations. | JACS Au | 2024 | https://conductscience.org/library/papers/38274251 | PubMed |
| 7 | 26192747 | Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice. | Nat Neurosci | 2015 | https://conductscience.org/library/papers/26192747 | PubMed |
| 8 | 19284597 | The role of tau in neurodegeneration. | Mol Neurodegener | 2009 | https://conductscience.org/library/papers/19284597 | PubMed |
| 9 | 1421571 | Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. | Mol Biol Cell | 1992 | https://conductscience.org/library/papers/1421571 | PubMed |
| 10 | 35806324 | Tau as a Biomarker of Neurodegeneration. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35806324 | PubMed |
| 11 | 26877193 | FLEXITau: Quantifying Post-translational Modifications of Tau Protein in Vitro and in Human Disease. | Anal Chem | 2016 | https://conductscience.org/library/papers/26877193 | PubMed |
| 12 | 16908029 | Folding of the repeat domain of tau upon binding to lipid surfaces. | J Mol Biol | 2006 | https://conductscience.org/library/papers/16908029 | PubMed |
| 13 | 28927263 | Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease. | Mol Cells | 2017 | https://conductscience.org/library/papers/28927263 | PubMed |
| 14 | 35181198 | Tau liquid-liquid phase separation in neurodegenerative diseases. | Trends Cell Biol | 2022 | https://conductscience.org/library/papers/35181198 | PubMed |
| 15 | 23772223 | What Renders TAU Toxic. | Front Neurol | 2013 | https://conductscience.org/library/papers/23772223 | PubMed |
| 16 | 26635213 | Tau and neurodegenerative disease: the story so far. | Nat Rev Neurol | 2016 | https://conductscience.org/library/papers/26635213 | PubMed |
| 17 | 35525497 | Tau Aggregation. | Neuroscience | 2023 | https://conductscience.org/library/papers/35525497 | PubMed |
| 18 | 21215781 | Post-translational modifications of tau protein: implications for Alzheimer's disease. | Neurochem Int | 2011 | https://conductscience.org/library/papers/21215781 | PubMed |
| 19 | 22817713 | Tau oligomers and tau toxicity in neurodegenerative disease. | Biochem Soc Trans | 2012 | https://conductscience.org/library/papers/22817713 | PubMed |
| 20 | 25378699 | SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25378699 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42421538 | 0N4R Tau aggregates producing morphologically different and structurally similar "on-path" and "off-path" oligomers. | Chem Commun (Camb) | 2026 | https://conductscience.org/library/papers/42421538 | PubMed |
| 42192571 | Biophysical assessment of the molecular mechanisms of Tau aggregation and its role in Alzheimer's disease. | Protein Sci | 2026 | https://conductscience.org/library/papers/42192571 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| RMDN1 | 51115 | PubTator's text mining | https://conductscience.org/library/genes/51115 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42192571
GET https://conductscience.org/api/papers/v1/42192571/references?page=2